Therefore, more investigations are needed on how specific bacteria or their products can stimulate the cGAS-STING pathway and enhance the anti-tumor immune response, which may promote the development of novel therapeutic strategies or interventions for CRC treatment. The gene discussed is STING1; the disease is neoplasm.